Spruce Biosciences, Inc. Banner Image

Spruce Biosciences, Inc.

  • Ticker SPRB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Spruce Biosciences, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). SpruceMore is also developing tildacerfont for women suffering from polycystic ovary syndrome (PCOS) with primary adrenal androgen excess.
Spruce Biosciences, Inc.

Most Recent Annual Report

Spruce Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Spruce Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!